Since IL-6 is the main driver of CRP production, it is not surprising that higher serum levels of IL-6 have been described in both SpA and IBD patients, though the clinical utility of serum IL-6 measurement is uncertain. The gene discussed is CRP; the disease is inflammatory bowel disease.